Ensign Peak Advisors’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-21,660
Closed -$522K 2084
2022
Q3
$522K Hold
21,660
﹤0.01% 1429
2022
Q2
$681K Hold
21,660
﹤0.01% 1316
2022
Q1
$953K Hold
21,660
﹤0.01% 1234
2021
Q4
$942K Sell
21,660
-37,040
-63% -$1.45M ﹤0.01% 1322
2021
Q3
$1.84M Hold
58,700
﹤0.01% 1174
2021
Q2
$2.48M Hold
58,700
0.01% 995
2021
Q1
$2.21M Buy
58,700
+4,600
+9% +$144K ﹤0.01% 1062
2020
Q4
$1.46M Buy
54,100
+26,800
+98% +$689K ﹤0.01% 1225
2020
Q3
$686K Buy
27,300
+16,900
+163% +$246K ﹤0.01% 1445
2020
Q2
$79K Buy
10,400
+7,200
+225% +$52.7K ﹤0.01% 1644
2020
Q1
$29K Buy
+3,200
New +$19.3K ﹤0.01% 1616

Other funds holding ACH

Ensign Peak Advisors's ACH Position: Q4 2022 in Review

Ensign Peak Advisors sold out of Accendra Health (ACH) in Q4 2022, closing a stake of 21,660 shares — an estimated $522K sold.

Ensign Peak Advisors first reported a position in ACH in Q1 2020 and held it in 11 quarters. The position peaked at $2.48M in Q2 2021. 219 funds tracked by Wall St. Rank hold ACH as of Q4 2022.

  • Ensign Peak Advisors reported no remaining Accendra Health position as of Q4 2022 after selling out during the quarter.
  • Ensign Peak Advisors sold 21,660 Accendra Health shares in Q4 2022, an estimated $522K.
  • Ensign Peak Advisors first reported a position in Accendra Health in Q1 2020 and held it in 11 quarters.
  • Ensign Peak Advisors's Accendra Health position peaked at $2.48M in Q2 2021.
  • 219 funds tracked by Wall St. Rank held Accendra Health as of Q4 2022.

Based on Ensign Peak Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.